Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

RESMED, INC.

(RMD)
  Report
Delayed Nyse  -  04:00 2022-12-01 pm EST
229.34 USD   -0.37%
11/23Insider Sell: Resmed
MT
11/22ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions
GL
11/22ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Sell: Resmed

09/19/2022 | 07:18am EST


ę MT Newswires 2022
All news about RESMED, INC.
11/23Insider Sell: Resmed
MT
11/22ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Ma..
GL
11/22ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Ma..
AQ
11/17Resmed : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
11/17Resmed Inc : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
11/17ResMed Inc Provides Information to the Shareholders
CI
11/17Insider Sell: Resmed
MT
11/16ResMed Opens Manufacturing Centre in Singapore, Expanding Manufacturing Footprint to Su..
CI
11/16Resmed Inc. Appoints Sandeep Gulati as General Manager, South Asia
CI
11/16Resmed : Opens Manufacturing Centre in Singapore, Expanding Manufacturing Footprint to Sup..
PU
More news
Analyst Recommendations on RESMED, INC.
More recommendations
Financials (USD)
Sales 2023 3 987 M - -
Net income 2023 892 M - -
Net Debt 2023 808 M - -
P/E ratio 2023 37,3x
Yield 2023 0,79%
Capitalization 33 721 M 33 721 M -
EV / Sales 2023 8,66x
EV / Sales 2024 7,81x
Nbr of Employees 8 160
Free-Float 76,8%
Chart RESMED, INC.
Duration : Period :
ResMed, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RESMED, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 230,20 $
Average target price 251,67 $
Spread / Average Target 9,33%
EPS Revisions
Managers and Directors
Michael J. Farrell Director-Business Development
Robert Andrew Douglas Vice President-Corporate Marketing
Brett A. Sandercock Chief Financial Officer
Peter C. Farrell Non-Executive Chairman
Carlos M. Nunez Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
RESMED, INC.-11.62%33 721
THERMO FISHER SCIENTIFIC-16.04%220 754
DANAHER CORPORATION-16.90%199 032
INTUITIVE SURGICAL, INC.-27.97%95 552
BOSTON SCIENTIFIC CORPORATION4.76%64 841
SIEMENS HEALTHINEERS AG-23.03%58 421